Camille Introcaso, MD
Dermatology · Marlton, NJNPI 1912067836
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,750 of the $22,750 with a category attached, or 73.6%. Helsinn Therapeutics (U.S.), Inc. accounts for 80.5% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2022 at $6,667 and has fallen 87.7% since, to $822 in 2025. Among dermatology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $130.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Helsinn Therapeutics (U.S.), Inc.$18K
- Sanofi$2K
- AbbVie$551
- Novartis$218
- Johnson & Johnson$180
- Pfizer$151
- plus $2K from 23 others
What the payments were for
- Consulting fees$1,6867%
- Speaking & faculty fees$16,75074%
- Travel & lodging$1,1925%
- Food & beverage$3,00513%
- Education$1171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Helsinn Therapeutics (U.S.), Inc. | 16 | $18,313 |
| Sanofi | 8 | $1,833 |
| AbbVie(2 entities) | 31 | $551 |
| Novartis | 12 | $218 |
| Johnson & Johnson | 6 | $180 |
| Pfizer | 9 | $151 |
| Regeneron Healthcare Solutions, Inc. | 8 | $141 |
| LEO Pharma Inc. | 9 | $138 |
| Sun Pharmaceutical Industries Inc. | 8 | $129 |
| Lilly USA, LLC | 8 | $124 |
| Organon | 9 | $117 |
| Arcutis Biotherapeutics, Inc. | 7 | $113 |
| Amgen | 5 | $92 |
| Galderma Laboratories, L.p. | 6 | $92 |
| E.r. Squibb & Sons, L.L.C. | 5 | $85 |
| Nobelpharma America, LLC | 4 | $79 |
| Incyte Corporation | 4 | $67 |
| UCB, Inc. | 3 | $53 |
| Bristol Myers Squibb | 2 | $42 |
| Journey Medical Corporation | 3 | $42 |
| Boehringer Ingelheim | 2 | $36 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $27 |
| DUSA Pharmaceuticals, Inc. | 1 | $21 |
| Krystal Biotech Inc | 1 | $21 |
| Biofrontera Inc. | 1 | $20 |
| Botanix SB Inc | 1 | $19 |
| Sandoz | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| Dermavant Sciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,750 in reported general payments places this provider in the 90th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 22 | $104,959 |
| Humira(Cf) PenAdalimumab | 12 | $85,496 |
| Dupixent PenDupilumab | 14 | $58,012 |
| Dupixent SyringeDupilumab | 12 | $42,360 |
| Ketoconazole | 134 | $3,276 |
| Tacrolimus | 26 | $2,389 |
| Fluorouracil | 39 | $2,279 |
| Clobetasol Propionate | 31 | $1,793 |
| Triamcinolone Acetonide | 141 | $1,383 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 50 | $1,192 |
| Clindamycin Phosphate | 36 | $986 |
| ValacyclovirValacyclovir Hcl | 33 | $885 |
| Doxycycline Hyclate | 15 | $804 |
| Metronidazole | 20 | $662 |
| Betamethasone Dipropionate | 16 | $618 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $92 | $104,95922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 394 dermatology providers in New Jersey.
Other dermatology in Marlton
- Patrick McMahonMarlton$133K
- Omar NoorSomerset$4.5M
- Linda Cappiello-LindsleyHoboken$2.3M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
- Brian MachlerFlorham Park$346K
- Jeanine DownieMontclair$327K
- Aanand GeriaRutherford$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.